WALTHAM, Mass., Mar 02, 2010 (BUSINESS WIRE) — NeuroMetrix, Inc. (NURO 2.08, -0.02, -0.95%), a health care company transforming patient care through neurotechnology, today announced that Thomas T. Higgins, Chief Financial Officer, will be presenting at the Canaccord Adams Musculoskeletal Conference in New Orleans on Tuesday, March 9, 2010.
NeuroMetrix’s presentation is scheduled for Tuesday, March 9, 2010 at 1:20pm (CST). A live audio webcast will be available on the investor relations section of our corporate website — www.neurometrix.com. This webcast will be archived after the live event.
NeuroMetrix is a science-based health care company transforming patient care through neurotechnology. We provide innovative products for preservation and restoration of nerve and spinal cord function, and pain control. To date, our focus has been primarily on the assessment of neuropathies. Neuropathies affect the peripheral nerves and parts of the spine and are frequently caused by or associated with carpal tunnel syndrome, diabetes, sciatica, and other clinical disorders. We market systems for the performance of nerve conduction studies and needle electromyography procedures. Our product pipeline includes a system designed to deliver pharmacologic agents such as anesthetics and corticosteroids in close proximity to nerves for regional anesthesia, pain control, and the treatment of focal neuropathies. We are also developing devices and pharmaceutical agents to treat peripheral nerve and spinal cord injuries. For more information, visit www.neurometrix.com.